Systematic analysis of TruSeq, SMARTer and SMARTer Ultra-Low RNA-seq kits for standard, low and ultra-low quantity samples.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
17 05 2019
Historique:
received: 10 01 2019
accepted: 01 05 2019
entrez: 19 5 2019
pubmed: 19 5 2019
medline: 21 10 2020
Statut: epublish

Résumé

High-throughput RNA-sequencing has become the gold standard method for whole-transcriptome gene expression analysis, and is widely used in numerous applications to study cell and tissue transcriptomes. It is also being increasingly used in a number of clinical applications, including expression profiling for diagnostics and alternative transcript detection. However, despite its many advantages, RNA sequencing can be challenging in some situations, for instance in cases of low input amounts or degraded RNA samples. Several protocols have been proposed to overcome these challenges, and many are available as commercial kits. In this study, we systematically test three recent commercial technologies for RNA-seq library preparation (TruSeq, SMARTer and SMARTer Ultra-Low) on human biological reference materials, using standard (1 mg), low (100 ng and 10 ng) and ultra-low (<1 ng) input amounts, and for mRNA and total RNA, stranded and unstranded. The results are analyzed using read quality and alignment metrics, gene detection and differential gene expression metrics. Overall, we show that the TruSeq kit performs well with an input amount of 100 ng, while the SMARTer kit shows decreased performance for inputs of 100 and 10 ng, and the SMARTer Ultra-Low kit performs relatively well for input amounts <1 ng. All the results are discussed in detail, and we provide guidelines for biologists for the selection of an RNA-seq library preparation kit.

Identifiants

pubmed: 31101892
doi: 10.1038/s41598-019-43983-0
pii: 10.1038/s41598-019-43983-0
pmc: PMC6525156
doi:

Substances chimiques

RNA, Messenger 0
Reagent Kits, Diagnostic 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7550

Références

Nat Biotechnol. 2014 Sep;32(9):888-95
pubmed: 25150837
Ann Oncol. 2015 Sep;26 Suppl 5:v8-30
pubmed: 26314782
BMC Genomics. 2014 Dec 11;15:1087
pubmed: 25495041
Nat Biotechnol. 2014 Sep;32(9):915-925
pubmed: 25150835
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Mol Neurodegener. 2008 Jul 10;3:8
pubmed: 18616804
Nat Biotechnol. 2014 Sep;32(9):903-14
pubmed: 25150838
Genome Res. 2008 Sep;18(9):1509-17
pubmed: 18550803
BMC Genomics. 2017 Jun 5;18(1):442
pubmed: 28583074
Nat Methods. 2013 Jul;10(7):623-9
pubmed: 23685885
Oncogene. 2015 Jan 2;34(1):1-14
pubmed: 24441040
Nat Biotechnol. 2006 Sep;24(9):1151-61
pubmed: 16964229
BMC Genomics. 2014 Jun 02;15:419
pubmed: 24888378
Nat Methods. 2010 Sep;7(9):709-15
pubmed: 20711195
Bioinformatics. 2015 Jan 15;31(2):166-9
pubmed: 25260700
Nat Rev Genet. 2016 May;17(5):257-71
pubmed: 26996076
Nucleic Acids Res. 2011 Oct;39(18):e120
pubmed: 21737426
Science. 2008 Aug 15;321(5891):956-60
pubmed: 18599741
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Genome Biol. 2014;15(12):550
pubmed: 25516281
J Biomol Tech. 2015 Apr;26(1):4-18
pubmed: 25649271
Nat Rev Genet. 2009 Jan;10(1):57-63
pubmed: 19015660
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Genome Res. 2015 Sep;25(9):1372-81
pubmed: 26253700
Genome Biol. 2014 Feb 03;15(2):R29
pubmed: 24485249
BMC Med Genet. 2011 Mar 11;12:37
pubmed: 21396098
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
Genome Biol. 2013 Apr 25;14(4):R36
pubmed: 23618408
BMC Biotechnol. 2015 Jul 30;15:65
pubmed: 26223446

Auteurs

Marie-Ange Palomares (MA)

Centre National de Recherche en Génomique Humaine (CNRGH), Institut de Biologie François Jacob, CEA, 91057, Evry, France.
Université Paris-Saclay, 91190, Saint-Aubin, France.

Cyril Dalmasso (C)

Laboratoire de Mathématiques et Modélisation ďÉvry (LaMME), Université ďEvry Val ďEssonne, 91000, Evry, France.
UMR CNRS 8071, 91000, Evry, France.
Ecole Nationale Supérieure ďInformatique pour l'Industrie et l'Entreprise, ENSIIE, 91000, Evry, France.
USC INRA, 91000, Evry, France.

Eric Bonnet (E)

Centre National de Recherche en Génomique Humaine (CNRGH), Institut de Biologie François Jacob, CEA, 91057, Evry, France. eric.bonnet@cng.fr.
Université Paris-Saclay, 91190, Saint-Aubin, France. eric.bonnet@cng.fr.

Céline Derbois (C)

Centre National de Recherche en Génomique Humaine (CNRGH), Institut de Biologie François Jacob, CEA, 91057, Evry, France.
Université Paris-Saclay, 91190, Saint-Aubin, France.

Solène Brohard-Julien (S)

Centre National de Recherche en Génomique Humaine (CNRGH), Institut de Biologie François Jacob, CEA, 91057, Evry, France.
Université Paris-Saclay, 91190, Saint-Aubin, France.

Christophe Ambroise (C)

Laboratoire de Mathématiques et Modélisation ďÉvry (LaMME), Université ďEvry Val ďEssonne, 91000, Evry, France.
UMR CNRS 8071, 91000, Evry, France.
Ecole Nationale Supérieure ďInformatique pour l'Industrie et l'Entreprise, ENSIIE, 91000, Evry, France.
USC INRA, 91000, Evry, France.

Christophe Battail (C)

Centre National de Recherche en Génomique Humaine (CNRGH), Institut de Biologie François Jacob, CEA, 91057, Evry, France.
Université Paris-Saclay, 91190, Saint-Aubin, France.

Jean-François Deleuze (JF)

Centre National de Recherche en Génomique Humaine (CNRGH), Institut de Biologie François Jacob, CEA, 91057, Evry, France.
Université Paris-Saclay, 91190, Saint-Aubin, France.

Robert Olaso (R)

Centre National de Recherche en Génomique Humaine (CNRGH), Institut de Biologie François Jacob, CEA, 91057, Evry, France.
Université Paris-Saclay, 91190, Saint-Aubin, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH